8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2019 / Comprehensive narrative review
This review examined human studies on plant-based dietary patterns and polyphenol-rich foods regarding age-related cognitive decline and cognitive function. Currently, direct evidence supporting vegetarian diets for preventing cognitive decline is lacking. However, emerging evidence supports plant-based patterns like the Mediterranean diet, and randomized clinical trials support plant foods such as citrus fruits, grapes, berries, cocoa, nuts, green tea, and coffee in improving specific cognitive domains, notably frontal executive function.
Rajaram S, Jones J, Lee GJ Adv Nutr, 2019. PMID 31728502
2013 / Narrative review
This review evaluates evidence regarding commonly consumed phytonutrients—including lycopene and polyphenols from tea, grape seed, citrus fruit, olive, and dried plum—and their role in bone health during aging. Current evidence remains insufficient to establish clear links or generate precise dietary recommendations due to mixed findings and scarce clinical data. Future clinical trials evaluating determinants of bone strength, as well as combinations with calcium and vitamin D, are needed.
Sacco SM, Horcajada MN, Offord E Br J Clin Pharmacol, 2013. PMID 23384080
2012 / Narrative review
This review discusses the potential role of plant polyphenols and fruit products in treating age-related cognitive disorders and dementia. Blueberry, strawberry, blackberry, grape, and plum juices or extracts have been tested in cognitively impaired rodents, and small human trials have examined grape and blueberry juice. Specific polyphenols like resveratrol and pterostilbene have been studied or shown to improve cognition in rodents. Future human trials need to consider poor bioavailability, optimal timing of therapy, and the appropriate form of treatment.
Cherniack EP Br J Nutr, 2012. PMID 22475317
2012 / Narrative review
This review evaluated animal and cellular studies of dried plum, citrus, berry fruits, and bioactive compounds (lycopene, phenolics, flavonoids, resveratrol, phloridzin, and pectin) alongside human studies of dried plum and lycopene. Cross-sectional studies show a positive association between higher fruit intake and higher bone mineral density. Animal studies suggest antioxidant-rich fruits promote higher bone mass and strength by enhancing bone formation and suppressing resorption through antioxidant or anti-inflammatory pathways.
Shen CL, von Bergen V, Chyu MC, et al. Nutr Res, 2012. PMID 23244535
2011 / Narrative review
This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.
Chachay VS, Kirkpatrick CM, Hickman IJ, et al. Br J Clin Pharmacol, 2011. PMID 21410504